106 related articles for article (PubMed ID: 27904987)
1. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma.
Iaccheri B; Fiore T; Cerquaglia A; Lupidi M; Cagini C
Int Ophthalmol; 2017 Dec; 37(6):1333-1335. PubMed ID: 27904987
[TBL] [Abstract][Full Text] [Related]
2. [Research progress in primary intraocular lymphoma].
Li M; Ye J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):795-800. PubMed ID: 26693776
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.
Coupland SE; Bechrakis NE; Anastassiou G; Foerster AM; Heiligenhaus A; Pleyer U; Hummel M; Stein H
Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):860-70. PubMed ID: 14605902
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how?
Hwang CS; Yeh S; Bergstrom CS
Int Ophthalmol Clin; 2014; 54(2):155-71. PubMed ID: 24613891
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause.
Oahalou A; Schellekens PA; de Groot-Mijnes JD; Rothova A
Retina; 2014 Jan; 34(1):108-14. PubMed ID: 23619637
[TBL] [Abstract][Full Text] [Related]
6. Combined phacoemulsification, primary intraocular lens implantation, and pars plana vitrectomy in children with uveitis.
Pålsson S; Nyström A; Sjödell L; Jakobsson G; Byhr E; Andersson Grönlund M; Zetterberg M
Ocul Immunol Inflamm; 2015 Apr; 23(2):144-51. PubMed ID: 24564567
[TBL] [Abstract][Full Text] [Related]
7. DIAGNOSTIC YIELD OF IN VITRO VITREOUS BIOPSY FOR INTRAOCULAR LYMPHOMA AT VARIABLE VITREOUS CUTTER SPEEDS USING 25-GAUGE VITRECTOMY.
Tekumalla S; Xu D; Awh K; Philp N; Milman T; Garg S
Retina; 2023 Jun; 43(6):1005-1009. PubMed ID: 36735414
[TBL] [Abstract][Full Text] [Related]
8. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis.
Androudi S; Ahmed M; Fiore T; Brazitikos P; Foster CS
J Cataract Refract Surg; 2005 Mar; 31(3):472-8. PubMed ID: 15811733
[TBL] [Abstract][Full Text] [Related]
9. [Importance of diagnostic and therapeutic pars plana vitrectomy in endogenous uveitis].
Ríhová E; Sisková A; Jandusová J; Dotrelová D; Diblík P; Sach J
Cesk Slov Oftalmol; 2003 Nov; 59(6):373-80. PubMed ID: 14740382
[TBL] [Abstract][Full Text] [Related]
10. Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts Eye Research and Surgery Institution experience.
Giuliari GP; Chang PY; Thakuria P; Hinkle DM; Foster CS
Eye (Lond); 2010 Jan; 24(1):7-13. PubMed ID: 20057512
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic testing of vitrectomy specimens.
Davis JL; Miller DM; Ruiz P
Am J Ophthalmol; 2005 Nov; 140(5):822-829. PubMed ID: 16310459
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of intraocular lesions using vitreous humor and intraocular perfusion fluid cytology: Experience with 83 Cases.
Kinoshita Y; Takasu K; Kobayashi TK; Yuri T; Tsubura A; Shikata N
Diagn Cytopathol; 2015 May; 43(5):353-9. PubMed ID: 25334001
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy.
Venkatesh P; Gogia V; Khanduja S; Gupta S; Kumar L; Garg S
J Cancer Res Ther; 2015; 11(3):668. PubMed ID: 26458712
[TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study.
Quinones K; Choi JY; Yilmaz T; Kafkala C; Letko E; Foster CS
Ocul Immunol Inflamm; 2010 Oct; 18(5):411-7. PubMed ID: 20735289
[TBL] [Abstract][Full Text] [Related]
15. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
[TBL] [Abstract][Full Text] [Related]
16. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
[TBL] [Abstract][Full Text] [Related]
17. THERAPEUTIC VITRECTOMY AS AN ADJUNCT TREATMENT TO SYSTEMIC CHEMOTHERAPY FOR INTRAOCULAR LYMPHOMA.
Bever GJ; Kim DJ; Afshar AR; Rubenstein JL; Damato BE
Retin Cases Brief Rep; 2020; 14(2):116-119. PubMed ID: 29210961
[TBL] [Abstract][Full Text] [Related]
18. Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome).
Coupland SE; Perez-Canto A; Hummel M; Stein H; Heimann H
Graefes Arch Clin Exp Ophthalmol; 2005 Sep; 243(9):847-52. PubMed ID: 15909161
[TBL] [Abstract][Full Text] [Related]
19. Twenty-three-gauge pars plana vitrectomy, Densiron-68, and 360° endolaser versus combined 20-gauge pars plana vitrectomy, scleral buckle, and SF6 for pseudophakic retinal detachment with inferior retinal breaks.
Romano MR; Angi M; Valldeperas X; Costagliola C; Vinciguerra P
Retina; 2011 Apr; 31(4):686-91. PubMed ID: 21386767
[TBL] [Abstract][Full Text] [Related]
20. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.
Tranos P; Scott R; Zambarakji H; Ayliffe W; Pavesio C; Charteris DG
Br J Ophthalmol; 2006 Sep; 90(9):1107-10. PubMed ID: 16723360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
